Structural basis of a small molecule targeting RNA for a specific splicing correction

Splicing modifiers promoting SMN2 exon 7 inclusion have the potential to treat spinal muscular atrophy, the leading genetic cause of infantile death. The small molecules are SMN2 exon 7 selective and act during the early stages of spliceosome assembly. Here, we show at atomic resolution how the drug...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Nat Chem Biol
Egile Nagusiak: Campagne, Sébastien, Boigner, Sarah, Rüdisser, Simon, Moursy, Ahmed, Gillioz, Laurent, Knörlein, Anna, Hall, Jonathan, Ratni, Hasane, Cléry, Antoine, Allain, Frédéric H-T.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7617061/
https://ncbi.nlm.nih.gov/pubmed/31636429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41589-019-0384-5
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak